428 related articles for article (PubMed ID: 18567839)
21. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
22. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
[TBL] [Abstract][Full Text] [Related]
23. Absence of complement factor H reduces physical performance in C57BL6 mice.
Seldeen KL; Thiyagarajan R; Redae Y; Jacob A; Troen BR; Quigg RJ; Alexander JJ
Immunobiology; 2020 Sep; 225(5):152003. PubMed ID: 32962822
[TBL] [Abstract][Full Text] [Related]
24. Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4
Hu X; Li X; Hu C; Qin L; He R; Luo L; Tang W; Feng J
Sci Rep; 2017 Nov; 7(1):15207. PubMed ID: 29123203
[TBL] [Abstract][Full Text] [Related]
25. Complement C5a exacerbates acute lung injury induced through autophagy-mediated alveolar macrophage apoptosis.
Hu R; Chen ZF; Yan J; Li QF; Huang Y; Xu H; Zhang X; Jiang H
Cell Death Dis; 2014 Jul; 5(7):e1330. PubMed ID: 25032853
[TBL] [Abstract][Full Text] [Related]
26. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
[TBL] [Abstract][Full Text] [Related]
27. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
[TBL] [Abstract][Full Text] [Related]
28. Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.
Qing X; Koo GC; Salmon JE
Eur J Immunol; 2012 Jul; 42(7):1723-34. PubMed ID: 22535677
[TBL] [Abstract][Full Text] [Related]
29. Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a.
Silawal S; Kohl B; Shi J; Schulze-Tanzil G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803624
[TBL] [Abstract][Full Text] [Related]
30. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
De Hoog VC; Timmers L; Van Duijvenvoorde A; De Jager SC; Van Middelaar BJ; Smeets MB; Woodruff TM; Doevendans PA; Pasterkamp G; Hack CE; De Kleijn DP
Cardiovasc Res; 2014 Sep; 103(4):521-9. PubMed ID: 24935433
[TBL] [Abstract][Full Text] [Related]
31. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
[TBL] [Abstract][Full Text] [Related]
32. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
Yuan B; Fu F; Huang S; Lin C; Yang G; Ma K; Shi H; Yang Z
Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
[TBL] [Abstract][Full Text] [Related]
33. Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.
Pan H; Shen Z; Mukhopadhyay P; Wang H; Pacher P; Qin X; Gao B
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F496-504. PubMed ID: 19144695
[TBL] [Abstract][Full Text] [Related]
34. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
[TBL] [Abstract][Full Text] [Related]
35. An essential role for C5aR signaling in the optimal induction of a malaria-specific CD4+ T cell response by a whole-killed blood-stage vaccine.
Liu T; Xu G; Guo B; Fu Y; Qiu Y; Ding Y; Zheng H; Fu X; Wu Y; Xu W
J Immunol; 2013 Jul; 191(1):178-86. PubMed ID: 23709683
[TBL] [Abstract][Full Text] [Related]
36. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
37. The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model.
Liang DY; Li X; Shi X; Sun Y; Sahbaie P; Li WW; Clark DJ
Pain; 2012 Feb; 153(2):366-372. PubMed ID: 22137294
[TBL] [Abstract][Full Text] [Related]
38. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
Zaal A; van Ham SM; Ten Brinke A
Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
[TBL] [Abstract][Full Text] [Related]
40. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
